AZD-2265
N/A
Report date: 2026/05/18 20:02:07
Base Information
Drug NameAZD-2265
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesAstrazeneca Ab
China Registration ClassN/A
Develop Information
Active CompaniesAstrazeneca PlcAstrazeneca Ab
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A